Methotrexat Orion rheuma/derm 2.5 mg

Methotrexat Orion rheuma/derm 2.5 mg is a medicine authorised by Swissmedic under authorisation number 66019. The authorisation holder is Orion Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 June 2017 and the authorisation is valid without a time limit. ATC code L04AX03 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 66019
  • ATC L04AX03
  • Synthetic medicines
Authorisation data
Authorisation number66019
NameMethotrexat Orion rheuma/derm 2.5 mg
Full nameMethotrexat Orion rheuma/derm 2.5 mg, Tabletten
Authorisation holderOrion Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AX03
First authorisation15 June 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Methotrexat Orion rheuma/derm 2.5 mg, TablettenA15 June 2017
2Methotrexat Orion rheuma/derm 10 mg, TablettenA15 June 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
320Tablette(n)L04AX0307.10.6.A
520Tablette(n)L04AX0307.10.6.A
410Tablette(n)L04AX0307.10.6.A
610Tablette(n)L04AX0307.10.6.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Methotrexat Orion rheuma/derm 2.5 mg authorised in Switzerland?

Yes. Methotrexat Orion rheuma/derm 2.5 mg is authorised by Swissmedic under authorisation number 66019, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Methotrexat Orion rheuma/derm 2.5 mg have?

Methotrexat Orion rheuma/derm 2.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Methotrexat Orion rheuma/derm 2.5 mg?

The authorisation holder is Orion Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com